Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics

被引：105
作者：
La Marca, A
Orvieto, R
Giulini, S
Jasonni, VM
Volpe, A
De Leo, V
机构：
[1] Policlin Modena, Inst Obstet & Gynecol, I-41100 Modena, Italy
[2] Univ Siena, I-53100 Siena, Italy
来源：
FERTILITY AND STERILITY | 2004年 / 82卷 / 04期
关键词：
D O I：
10.1016/j.fertnstert.2004.06.001
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
The aim of the present study was to examine the relationship between Mullerian-inhibiting substance (MIS) levels and metabolic characteristics in women with polycystic ovary syndrome. Increased ovarian MIS production may exert a paracrine negative control on follicle growth sufficiently to prevent selection of a dominant follicle. (C) 2004 by American Society for Reproductive Medicine.
引用
收藏
页码：970 / 972
页数：3
相关论文
共 50 条
  • [11] Relationship of bariatric surgery to Mullerian-inhibiting substance levels
    Merhi, Zaher O.
    Minkoff, Howard
    Feldman, Joseph
    Macura, Jerzy
    Rodriguez, Carlos
    Seifer, David B.
    FERTILITY AND STERILITY, 2008, 90 (01) : 221 - 224
  • [12] MULLERIAN-INHIBITING SUBSTANCE - AN UPDATE
    DONAHOE, PK
    BUDZIK, GP
    TRELSTAD, R
    MUDGETTHUNTER, M
    FULLER, A
    HUTSON, JM
    IKAWA, H
    HAYASHI, A
    MACLAUGHLIN, D
    RECENT PROGRESS IN HORMONE RESEARCH, 1982, 38 : 279 - 326
  • [13] GONADOTROPIN CONTROL OF MULLERIAN-INHIBITING SUBSTANCE
    BERCU, BB
    MORIKAWA, Y
    JACKSON, IMD
    DONAHOE, PK
    PEDIATRIC RESEARCH, 1979, 13 (02) : 142 - 142
  • [14] Serum mullerian-inhibiting substance in Down's syndrome pregnancies
    Seifer, David B.
    MacLaughlin, David T.
    Cuckle, Howard S.
    HUMAN REPRODUCTION, 2007, 22 (04) : 1017 - 1020
  • [15] MULLERIAN-INHIBITING SUBSTANCE - AN UPDATE - DISCUSSION
    PECK, EJ
    DONAHOE, PK
    SHAPIRO, J
    GLASSER, S
    BULLOCK, L
    LARNER, J
    FINDLAY, JK
    RAJ, MHG
    PAPKOFF, H
    BUDZIK, GP
    AHREN, K
    BLOSSEY, HC
    POMERANTZ, DK
    MOWSZOWICZ, I
    MONDER, C
    PLYMATE, SR
    ROSENWAKS, Z
    CROWLEY, WF
    NICOLL, CS
    RECENT PROGRESS IN HORMONE RESEARCH, 1982, 38 : 326 - 330
  • [16] MULLERIAN-INHIBITING SUBSTANCE IS PRESENT IN EMBRYONIC TESTES OF DOGS WITH PERSISTENT MULLERIAN DUCT SYNDROME
    MEYERSWALLEN, VN
    LEE, MM
    MANGANARO, TF
    KURODA, T
    MACLAUGHLIN, D
    DONAHOE, PK
    BIOLOGY OF REPRODUCTION, 1993, 48 (06) : 1410 - 1418
  • [17] IDENTIFICATION OF A RECEPTOR FOR HUMAN MULLERIAN-INHIBITING SUBSTANCE
    CATLIN, EA
    EZZELL, RM
    DONAHOE, PK
    GUSTAFSON, ML
    SON, EV
    MACLAUGHLIN, DT
    ENDOCRINOLOGY, 1993, 133 (06) : 3007 - 3013
  • [18] MULLERIAN-INHIBITING SUBSTANCE AS A CANCER THERAPEUTIC AGENT
    FULLER, AF
    KRANE, IM
    BUKZIK, G
    DONAHOE, PK
    GYNECOLOGIC ONCOLOGY, 1985, 20 (02) : 254 - 254
  • [19] Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome
    Apridonidze, T
    Essah, PA
    Iuorno, MJ
    Nestler, JE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) : 1929 - 1935
  • [20] THE IN-VIVO ROLES OF MULLERIAN-INHIBITING SUBSTANCE
    BEHRINGER, RR
    CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOL 29, 1994, 29 : 171 - 187
12345